Business
New Contract with Biopharmaceutical Company
New Contract with Biopharmaceutical Company.
About this update from Ixico Plc
[{"type":"text","content":"\n \nRNS Number : 6359R IXICO plc 25 September 2017 \n\n25 September 2017\n \nIXICO plc\n \n(\"IXICO\" or the \"Company\")\n \nIXICO to provide specialist MR and PET imaging services in Phase II Huntington's disease clinical trial\n \nIXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has signed a new contract with a North American based biopharmaceutical company. The contract value is £1.2m over a three year term. \n \nIXICO will provide its technology enabled imaging services in a Phase II clinical trial of a novel therapeutic to treat people with Huntington's disease. As part of the study, IXICO will use its TrialTracker™ digital platform and scientific services to standardise the acquisition and collection of both MRI and PET scans acquired at specialist imaging centres across North America. This data will be analysed using IXICO's proprietary image analysis workflows and algorithms to evaluate patient eligibility, monitor patient safety and quantify drug effects.\n \nGiulio Cerroni, Chief Executive of IXICO, said: \"We are delighted to continue our successful track record in Huntington's disease clinical studies, providing compliant data standardisation, collection and analysis to support regulatory submissions. This first contract with a new customer also demonstrates the momentum we are building with our commercially led growth strategy focused on serving the needs of the biopharmaceutical industry\".\n \nFor further information please contact:\n \n\n\n\n\nIXICO plc\nGiulio Cerroni, Chief Executive Officer\nSusan Lowther, Chief Financial Officer\n\n\n \nTel: +44 20 3763 7499\n\n\n\n\n\n\n\n\n\n\n\n\nShore Capital (Nomad and Broker)\nBidhi Bhoma / Edward Mansfield / James Wolfe\n\n\nTel: +44 20 7408 4090\n\n\n\n\n\n\n\n\n\n\n\n\nFTI Consulting Limited (Investor Relations)\nSimon Conway/Mo Noonan\n\n\nTel: +44 20 3727 1000\n\n\n\n\n \nAbout IXICO\n \nIXICO is the digital technologies company serving neuroscience. Our mission is to transform the pursuit of improving brain health through the application of digital technologies to neuroscience. IXICO's specialist data analytics services are used by the global pharmaceutical industry to select participants for clinical trials, assess the safety and efficacy of new drug...